The US government's investment in innovation has led to a major breakthrough for the 100,000 Americans living with sickle cell disease. Sickle cell disease causes chronic pain and serious health complications, disproportionately affecting Black and Hispanic Americans. The announcement by the FDA represents the power of medical innovation to improve lives and offers hope for developing treatments for other rare diseases. The government will continue its efforts to accelerate the development of cures for rare diseases and support medical research and innovation.